Protocol - Long COVID - Symptoms Due to COVID-19 - Allergies
Description
A self-administered questionnaire to better describe and understand the patient experience and recovery of those with confirmed or suspected COVID-19, with a specific emphasis on Long COVID experience especially with allergies.
Specific Instructions
None
Availability
This protocol is freely available; permission not required for use.
Protocol
Skin and Allergy Symptoms
1. Did you experience these symptoms, and when did you experience them?
Please mark symptoms for the first 4 weeks, then months (if applicable). Even if you have only experienced these symptoms for part of a week or month, please select it. If you experienced none of the symptoms in a set, select the checkbox (None of the below issues apply to me) above the grouped set.
[ ] None of the below skin and allergy symptoms apply to me
Skin and Allergy Symptoms
N/A | Week 1 | Week 2 | Week 3 | Week 4 | Month 2 | Month 3 | Month 4 | Month 5 | |
Peeling skin | [ ] | [ ] | [ ] | [ ] | [ ] | [ ] | [ ] | [ ] | [ ] |
Petechiae (tiny purple, red, or brown spots on the skin, usually on arms, legs, stomach, buttocks, and occasionally inside mouth or on eyelids) | [ ] | [ ] | [ ] | [ ] | [ ] | [ ] | [ ] | [ ] | [ ] |
COVID toes (discoloration, swelling, painful, or blistering toes) | [ ] | [ ] | [ ] | [ ] | [ ] | [ ] | [ ] | [ ] | [ ] |
Dermatographia (writing on your skin causes red lines where you scratched) | [ ] | [ ] | [ ] | [ ] | [ ] | [ ] | [ ] | [ ] | [ ] |
New allergies (food, chemical, environmental, etc) | [ ] | [ ] | [ ] | [ ] | [ ] | [ ] | [ ] | [ ] | [ ] |
Skin rashes | [ ] | [ ] | [ ] | [ ] | [ ] | [ ] | [ ] | [ ] | [ ] |
Other ________ | [ ] | [ ] | [ ] | [ ] | [ ] | [ ] | [ ] | [ ] | [ ] |
All Other Symptoms - Checkbox
2. Have you experienced any of these symptoms since the start of your COVID-19 illness? (Please choose all options that apply)
Skin and Allergy
[ ] New allergies (food, chemical, environmental, etc)
[ ] Heightened reaction to old allergies
[ ] Itchy skin
[ ] Itchy eyes
[ ] Itchy other ________
[ ] Brittle/discolored nail
[ ] Shingles
[ ] None of the above
Symptom Course
3. How severe were/are your symptoms over the course of the weeks/months?
If you experienced multiple severities for symptoms within the time period, select the most severe within that time period.
No symptom | Very Mild | Mild | Moderate | Severe | Very Severe | |
Week 1 | [ ] | [ ] | [ ] | [ ] | [ ] | [ ] |
Week 2 | [ ] | [ ] | [ ] | [ ] | [ ] | [ ] |
Week 3 | [ ] | [ ] | [ ] | [ ] | [ ] | [ ] |
Week 4 | [ ] | [ ] | [ ] | [ ] | [ ] | [ ] |
Month 2 | [ ] | [ ] | [ ] | [ ] | [ ] | [ ] |
Month 3 | [ ] | [ ] | [ ] | [ ] | [ ] | [ ] |
Month 4 | [ ] | [ ] | [ ] | [ ] | [ ] | [ ] |
Month 5 | [ ] | [ ] | [ ] | [ ] | [ ] | [ ] |
Month 6 | [ ] | [ ] | [ ] | [ ] | [ ] | [ ] |
Month 7+ | [ ] | [ ] | [ ] | [ ] | [ ] | [ ] |
4. Which of these descriptions appropriately describes your experience with relapses, and your symptom course overall? Please select all that apply:
[ ] My relapses happen in a regular pattern (monthly, daily, or weekly).
[ ] My relapses happen in an irregular pattern (randomly).
[ ] My relapses happen in response to a trigger (stress, alcohol, exercise/exertion, etc).
[ ] My relapses are getting shorter/easier over time.
[ ] My relapses are getting longer/harder over time.
[ ] My relapse severity has stayed about the same over time.
[ ] Overall, my symptoms have slowly gotten better over time.
[ ] Overall, my symptoms have stayed about the same over time.
[ ] Overall, my symptoms have slowly worsened over time.
[ ] I got worse rapidly.
[ ] I got better rapidly.
[ ] Other ___________
7. Which of these trigger a relapse or worsening of symptoms? Please select all that apply:
[ ] Stress
[ ] Alcohol
[ ] Caffeine
[ ] Heat
[ ] Period/menstruation
[ ] Week before period/menstruation
[ ] Exercise
[ ] Physical activity
[ ] Mental activity
[ ] Other ___________
Personnel and Training Required
None
Equipment Needs
None
Requirements
Requirement Category | Required |
---|---|
Major equipment | No |
Specialized training | No |
Specialized requirements for biospecimen collection | No |
Average time of greater than 15 minutes in an unaffected individual | No |
Mode of Administration
Self-administered questionnaire
Lifestage
Adult, Senior
Participants
Adults aged 18 years or older
Selection Rationale
PhenX used input from the PhenX Steering Committee to enable rapid response and release of COVID-19 related protocols in the Toolkit.
Language
English, Other languages available at source
Standards
Standard | Name | ID | Source |
---|
Derived Variables
None
Process and Review
Not Applicable
Protocol Name from Source
Online Survey on Recovery from COVID-19
Source
University College London. (2022). Online Survey on Recovery from COVID-19, Section “Allergies Section”.
General References
Neal C. Goldberg, Sabrina Poirier, Allison Kanas, Lisa McCorkell, Carrie Anna McGinn, Yochai Re’em, Kathi Kuehnel, Nina Muirhead, Tahlia Ruschioni, Susan Taylor-Brown & Leonard A. Jason (2022) A new clinical challenge: supporting patients coping with the long-term effects of COVID-19, Fatigue: Biomedicine, Health & Behavior, 10:4, 212-230, DOI: 10.1080/21641846.2022.2128576
Protocol ID
992013
Variables
Export VariablesVariable Name | Variable ID | Variable Description | dbGaP Mapping | |
---|---|---|---|---|
PX992013_Long_COVID_Symptoms_Allergies_Other_Covid_Symptoms | ||||
PX992013040100 | Have you experienced any of these symptoms more | N/A | ||
PX992013_Long_COVID_Symptoms_Allergies_Other_Covid_Symptoms_Itchy_Other | ||||
PX992013040200 | Have you experienced any of these symptoms more | N/A | ||
PX992013_Long_COVID_Symptoms_Allergies_Skin_Allergy_Symptoms_COVID_Toes | ||||
PX992013030400 | Did you experience these symptoms, and when more | N/A | ||
PX992013_Long_COVID_Symptoms_Allergies_Skin_Allergy_Symptoms_Dermatographia | ||||
PX992013030500 | Did you experience these symptoms, and when more | N/A | ||
PX992013_Long_COVID_Symptoms_Allergies_Skin_Allergy_Symptoms_New_Allergies | ||||
PX992013030600 | Did you experience these symptoms, and when more | N/A | ||
PX992013_Long_COVID_Symptoms_Allergies_Skin_Allergy_Symptoms_None | ||||
PX992013010100 | Did you experience these symptoms, and when more | N/A | ||
PX992013_Long_COVID_Symptoms_Allergies_Skin_Allergy_Symptoms_Peeling_Skin | ||||
PX992013010200 | Did you experience these symptoms, and when more | N/A | ||
PX992013_Long_COVID_Symptoms_Allergies_Skin_Allergy_Symptoms_Petechiae | ||||
PX992013030300 | Did you experience these symptoms, and when more | N/A | ||
PX992013_Long_COVID_Symptoms_Allergies_Skin_Allergy_Symptoms_Skin_Other | ||||
PX992013030800 | Did you experience these symptoms, and when more | N/A | ||
PX992013_Long_COVID_Symptoms_Allergies_Skin_Allergy_Symptoms_Skin_Other_Specify | ||||
PX992013030801 | Did you experience these symptoms, and when more | N/A | ||
PX992013_Long_COVID_Symptoms_Allergies_Skin_Allergy_Symptoms_Skin_Rashes | ||||
PX992013030700 | Did you experience these symptoms, and when more | N/A | ||
PX992013_Long_COVID_Symptoms_Allergies_Symptom_Courses_Replase | ||||
PX992013040100 | Which of these descriptions appropriately more | N/A | ||
PX992013_Long_COVID_Symptoms_Allergies_Symptom_Courses_Replase_Other | ||||
PX992013040200 | Which of these descriptions appropriately more | N/A | ||
PX992013_Long_COVID_Symptoms_Allergies_Symptom_Relapse_Trigger | ||||
PX992013050100 | Which of these trigger a relapse or more | N/A | ||
PX992013_Long_COVID_Symptoms_Allergies_Symptom_Relapse_Trigger_Other | ||||
PX992013050200 | Which of these trigger a relapse or more | N/A | ||
PX992013_Long_COVID_Symptoms_Allergies_Symptom_Severity_Month_2 | ||||
PX992013030500 | How severe were/are your symptoms over the more | N/A | ||
PX992013_Long_COVID_Symptoms_Allergies_Symptom_Severity_Month_3 | ||||
PX992013030600 | How severe were/are your symptoms over the more | N/A | ||
PX992013_Long_COVID_Symptoms_Allergies_Symptom_Severity_Month_4 | ||||
PX992013030700 | How severe were/are your symptoms over the more | N/A | ||
PX992013_Long_COVID_Symptoms_Allergies_Symptom_Severity_Month_5 | ||||
PX992013030800 | How severe were/are your symptoms over the more | N/A | ||
PX992013_Long_COVID_Symptoms_Allergies_Symptom_Severity_Month_6 | ||||
PX992013030900 | How severe were/are your symptoms over the more | N/A | ||
PX992013_Long_COVID_Symptoms_Allergies_Symptom_Severity_Month_7 | ||||
PX992013031000 | How severe were/are your symptoms over the more | N/A | ||
PX992013_Long_COVID_Symptoms_Allergies_Symptom_Severity_Week_1 | ||||
PX992013030100 | How severe were/are your symptoms over the more | N/A | ||
PX992013_Long_COVID_Symptoms_Allergies_Symptom_Severity_Week_2 | ||||
PX992013030200 | How severe were/are your symptoms over the more | N/A | ||
PX992013_Long_COVID_Symptoms_Allergies_Symptom_Severity_Week_3 | ||||
PX992013030300 | How severe were/are your symptoms over the more | N/A | ||
PX992013_Long_COVID_Symptoms_Allergies_Symptom_Severity_Week_4 | ||||
PX992013030400 | How severe were/are your symptoms over the more | N/A |
Measure Name
Long COVID - Symptoms Due to COVID-19
Release Date
March 17, 2023
Definition
This is a measure of an individual’s new or continuing COVID-19 symptoms.
Purpose
Presence of lingering COVID-19 symptoms is a sign of Long COVID, and use of this measure helps with understanding people’s experience with COVID-19 and implications of Long COVID.
Keywords
coronavirus, COVID-19, Allergies, University College London, UCL, skin
Measure Protocols
Publications
There are no publications listed for this protocol.